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Abstract
Inferring which protein species have been detected in bottom-up proteomics experiments has been 
a challenging problem for which solutions have been maturing over the past decade. While many 
inference approaches now function well in isolation, comparing and reconciling the results 
generated across different tools remains difficult. It presently stands as one of the greatest barriers 
in collaborative efforts such as the Human Proteome Project and public repositories like the 
PRoteomics IDEntifications (PRIDE) database. Here we present a framework for reporting protein 
identifications that seeks to improve capabilities for comparing results generated by different 
inference tools. This framework standardizes the terminology for describing protein identification 
results, associated with the HUPO-Proteomics Standards Initiative (PSI) mzIdentML standard, 
while still allowing for differing methodologies to reach that final state. It is proposed that 
developers of software for reporting identification results will adopt this terminology in their 
outputs. While the new terminology does not require any changes to the core mzIdentML model, it 
represents a significant change in practice, and, as such, the rules will be released via a new 
version of the mzIdentML specification (version 1.2) so that consumers of files are able to 
determine whether the new guidelines have been adopted by export software.
Keywords
protein identification; software; data standards; Proteomics Standards Initiative; XML
Introduction
In many proteomics workflows (so called bottom-up), proteins within the sample(s) are 
digested into peptides prior to analysis. This causes a loss of the link from an identified 
peptide to its parent protein, as many peptide sequences can be assigned to more than one 
protein. In such cases it is not possible to determine definitively which protein (or proteins) 
the peptide originated from and thus which proteins were present in the sample. Two 
proteins sharing one or more peptides may arise from the same gene but differ due to SNPs, 
post-translational cleavage (e.g. removal of a signal peptide), or alternative splicing; if 
arising from different genes they may be homologues (paralogues in a single species-derived 
database, or paralogues and orthologues if the search database contains proteins from 
multiple species), or unrelated but sharing a short sequence of amino acids. The concept of 
proteoform has been coined to describe the unit of protein as present in the cell and carrying 
a given sequence and a specific set of post-translational modifications (PTMs) [1]. It should 
be noted that PTMs can also introduce ambiguity in assignment of a parent protein, for 
example deamidation of asparagine is physically indistinguishable from aspartic acid, and as 
such different peptide sequences (from different proteins) could equally “explain” the same 
mass spectrum. Up to roughly the middle of the last decade it was common for investigators 
to report all protein sequences matching any putatively identified peptides, leading to highly 
inflated protein counts.
The so-called “protein inference” problem in proteomics aims to determine how many 
protein species have actually been detected and convey the remaining ambiguity in an 
optimal way, and has been tackled by many different groups [2-9]. Protein counting inflation 
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has been brought under control in the last few years, driven by advances in protein inference 
algorithms and perhaps more importantly, increased awareness of their importance driven by 
journal publication guidelines [10-12]. It is now generally expected by journals that rules of 
parsimony are applied in producing the list of proteins identified [13]; i.e. the shortest list of 
proteins that can adequately explain all of the data is submitted for publication. While this 
pressure has forced the numbers of detected proteins reported by different methods to 
converge to some extent, there remains greater heterogeneity in the second major concern of 
protein inference – conveying the ambiguity.
Whether a result of the output of an algorithm or a subsequent choice made by a user, the 
way that ambiguity is conveyed in a protein identification result can have a major effect on 
how that result can be compared to other results. Even if multiple results use the same 
protein identifier system and are derived from the same database searched (problems not 
directly addressed here), insufficient description of ambiguity in protein groups can cause 
failure to recognize common protein detections between results, causing falsely low 
apparent intersections. Additionally, different protein inference tools describe ambiguity in 
different ways with different terminology. While individual publications may no longer 
report inflated protein lists, because of the missing information about ambiguity and how 
this was handled by the software employed, it is presently not possible to compare or 
combine findings from multiple laboratories adequately, when a broad range of different 
tools is used.
The challenges of comparing protein identification results were highlighted by the ABRF 
(Association of Biomolecular Resource Facilities) Proteome Informatics Research Group 
(iPRG) in 2008 [14, 15] where the committee, entirely comprised of creators of protein 
inference tools, attempted to analyze a common dataset and determine a consensus protein 
identification result, each using their respective software. The committee agreed a common 
terminology for describing identification results: protein accession - one entry in a database 
searched; protein group - a set of protein accessions that have some independent evidence in 
common (evidence distinguishing them from all other proteins) – generally considered to be 
a single unit of (protein-level) identification in proteomics; and a protein cluster – a set of 
protein groups that share some evidence in common (e.g. some peptides/spectra shared 
between groups), but within which different groups also have evidence independent from 
each other (e.g. some peptides/spectra uniquely assigned to some groups only). The minimal 
list of proteins “identified” from a study should be the count of the number of protein 
groups, for example passing a given threshold (Figure 1A-C). In earlier work by Nesvizhskii 
and Aebersold at providing a consistent nomenclature [13], concepts of “protein”, “protein 
group” and “protein family” were defined – which are broadly consistent with the three 
main concepts in the iPRG nomenclature. In [13], further classifications of “distinct 
proteins”, “differentiable proteins”, “indistinguishable proteins”, “subset proteins” and 
“subsumable proteins” were also described. In this work, the (simpler) iPRG concepts are 
used throughout, as they were derived by a consensus of protein inference tool creators, 
including the lead author of [13].
Even with the exceptional advantage of having direct input from each tool’s creator, the 
synthesis exercise performed in iPRG2008 still proved time-consuming, requiring much 
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manual intervention. For repositories and collaborative studies to function, this same kind of 
synthesis needs to be accomplished not only without the benefit of direct interaction with 
software creators, but via automated computation. Additional standardization is needed to 
achieve this, which is the aim of this work.
The Proteomics Standards Initiative (PSI) is an entirely open collaboration of academic 
research groups, instrument and software vendors and journal representatives, which has 
been developing resources to facilitate data sharing and public deposition for over ten years 
[16]. Each PSI workgroup develops broadly three types of output: minimum reporting 
guidelines, standard data formats, and controlled vocabularies sets. The Minimum 
Information About a Proteomics Experiment (MIAPE) specifications are a set of modules 
that provide minimum reporting guidelines for specific experimental techniques or 
approaches [17]. Data format standards seek to improve data exchange between software 
packages and databases; efforts to date include mzML for MS data [18], mzIdentML for 
peptide and protein identification data [19] and new formats for quantitation results – 
mzQuantML [20] and mzTab [21]. Established controlled vocabularies (CVs) containing 
well-defined terminology to use within the data formats enable concepts to be 
unambiguously interpreted. Examples include the PSI-MOD [22] and Unimod [23] 
nomenclatures for describing peptide modifications and the PSI-MS CV [24] used in a 
variety of PSI standards.
The initial stable version of mzIdentML (version 1.1 [19]) has now become a well-
established standard for capturing the outputs of proteomic search engines, particularly the 
scores and statistical values associated with peptide-spectrum matches (PSMs). The 
mzIdentML version 1.1 specifications enabled protein identification results to be reported as 
grouped accessions (where shared peptide evidence exists) in a relatively flexible structure, 
with the intention that more robust guidelines could be developed later. In this work, we 
have now developed guidelines for reporting (grouped) protein identification results in a 
format that can be consumed and interpreted in an unambiguous manner, and supporting the 
majority of known approaches for inferring protein identifications. The guidelines do not 
require an update to the core mzIdentML structure (the XML Schema), but do represent a 
change in practice in how protein-level results should be encoded, and, as such, we are now 
releasing a new version of mzIdentML (version 1.2), so that consuming software is able to 
differentiate those following the new guidelines on protein reporting.
Methods
The guidelines reported here have been developed through an open consultation process at 
PSI meetings [16] and teleconferences. The guidelines have been formally captured in the 
mzIdentML specification document: http://code.google.com/p/psi-pi/source/browse/trunk/
specification_document/specdoc1_2/, supporting examples files (http://code.google.com/p/
psi-pi/source/browse/trunk/examples/) updates to the PSI-MS controlled vocabulary [24], a 
new mapping file indicating how the CV terms should be used within the format (http://
code.google.com/p/psi-pi/source/browse/trunk/cv/) and updates to the mzIdentML validator 
[25].
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mzIdentML overview
The mzIdentML standard has been designed to capture the outputs of peptide/protein 
identification software, such as sequence database search engines and search result 
verification/post-processing software. The format captures the software used, the sequence 
database searched, software parameters (including modifications) and output results – one or 
more lists of peptide-spectrum matches (PSMs) and the set of proteins inferred from those 
PSMs. Each PSM or protein identification can be reported with one or more scores or 
statistical measures, such as e-values or p-values (encoded using standard terminology from 
the PSI-MS CV), which allow subsequent manual or automated assessment of the quality of 
individual results. An up-to-date listing of software implementations for mzIdentML can be 
found here: http://www.psidev.info/tools-implementing-mzidentml.
Each mzIdentML file has a <SequenceCollection> containing elements called 
<DBSequence> (Figure 2A). <DBSequence> is a reusable (referenced from several 
elements in an mzIdentML file) representation of a single database entry, capturing the 
accession in the source database and optionally the protein sequence, description, taxonomy 
and so on. One or more <DBSequence> elements is referenced from every PSM (not shown 
on Figure 2), capturing all possible parent proteins for every peptide prior to protein 
inference. An mzIdentML file could in theory encode an entire search database (for example 
from a FASTA formatted file) in the <SequenceCollection>, although generally the 
<SequenceCollection> contains only the listing of all possible proteins mapped from PSMs, 
which is typically a superset of the protein accessions identified following protein inference.
The <ProteinDetectionList> contains a hierarchical structure in which the protein 
identifications are represented (Figure 2B). Each <ProteinDetectionList> contains 
<ProteinAmbiguityGroup> elements (here referred as PAG), each capturing a single 
identified protein or a group of proteins where there is some ambiguity in exactly which 
protein has been identified. Each protein within a group is recorded as an element called 
<ProteinDetectionHypothesis> (here referred as PDH). Each PDH references exactly one 
<DBSequence> element, indicating the database entry that has been potentially identified. 
Each PDH also references the set of PSMs on which it is based, completing the evidence 
trail for its identification (not shown on Figure 2). Also, each PDH has a mandatory true/
false attribute called passThreshold, indicating whether the protein identification is deemed 
to have passed a threshold reported elsewhere within the file. This attribute was included in 
mzIdentML 1.1 (and earlier releases) to allow the data producer to export identifications 
both above and below the threshold. However, no such attribute was also present on the 
protein group (PAG) level.
When the mzIdentML standard was completed as a stable release (version 1.1), a set of CV 
terms was added to the PSI-MS CV allowing basic annotations as to the role that each 
protein (PDH) played within its group (PAG) – intended to capture same-set, subset and 
subsumable relationships between PDHs. However, the original mzIdentML specification 
document did not enforce the use of these CV terms and provided little guidance on how 
more general grouping relationships should be captured. The result is that software reading 
mzIdentML files containing protein identification results would have difficulty comparing 
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the results exported from different packages. Specific problems that have been identified are 
as follows. Most critically, the specifications did not contain a clear statement in terms of 
how the concepts represented in Figure 1A-C should be mapped onto mzIdentML – e.g. 
different exporters could choose to map onto a PAG either a “cluster” or a “protein group” 
or, for some software packages that define sets/groups of proteins at yet further levels of 
granularity, something else. Second, when reading an mzIdentML file, the answer to a 
simple question “how many proteins were being reported as identified” could not be 
decisively determined, and different users or software could arrive at different answers (for 
example one might count PAGs or count PDHs). Third, the specification documentation was 
not clear on how the passThreshold attribute on PDH should be interpreted – potentially 
implying that this protein was determined as identified and representative of a group or only 
that it had statistically significant PSMs. In this manuscript, we describe work undertaken to 
formalize how protein inference should be reported in mzIdentML (although the guidelines 
could be adapted for other methods of reporting proteomics identification results), including 
the definition of a new set of CV terms that have been added to the PSI-MS CV.
Results and Discussion
The primary result reported here is a standardized set of rules for mapping the concepts 
represented in Figure 1 onto mzIdentML, as shown graphically in Figure 2 and as actual 
mzIdentML XML code in Figure 3. The following mappings and rules have now been 
established in this work - capitalized MUST, SHOULD and MAY have a formal 
interpretation by validation software:
1. As in mzIdentML version 1.1, a single protein accession that has been cited by 
software (Figure 1A) is captured in mzIdentML in <ProteinDetectionHypothesis> 
(PDH).
a. A PDH MAY contain scores or statistical values produced by the export 
software, encoded as CV terms.
2. A “protein group” (Figure 1B), representing a “biological entity” for which the 
software claims independent evidence is present, MUST be mapped onto 
<ProteinAmbiguityGroup> (PAG).
a. A PAG MAY have additional scores produced by the export software, 
encoded as CV terms.
3. The reporting of protein identification thresholds is now mapped onto PAGs. There 
is no desire to change the core XML Schema Document (XSD) for mzIdentML and 
as such, a new CV term “protein group passes threshold” value= “xsd:boolean” 
MUST be present on every PAG (MS:1002415). If no thresholding has been done 
by the software, all protein groups MUST be annotated as “protein group passes 
threshold” value= “true”.
a. The attribute passThreshold = “true∣false” remains present on PDH and 
MAY be used if software packages wish to report a two-level hierarchy of 
thresholds applied, however, it is not expected that consuming software will 
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use this attribute to determine which proteins have been reported as 
identified.
b. As in mzIdentML 1.1, the threshold applied to protein-level results MUST 
be present in the <ProteinDetectionProtocol>. However, the mzIdentML 1.1 
specifications implied that the threshold value present here was used to 
determine the passThreshold attribute on all PDH elements. In mzIdentML 
1.2, the threshold value reported here corresponds with PAG-level 
thresholding applied – either to a score reported specifically on each PAG 
itself, or a score on the PDH flagged as a “group representative”. In 
approaches that do not use the “group representative” CV term, there is an 
expectation that thresholds SHOULD be applied to scores reported at the 
PAG-level. The <ProteinDetectionProtocol> MUST contain either the “no 
threshold” term or a suitable score/value pair sourced from the PSI-MS CV – 
such as p-value, FDR, e-value and so on, determined by any type of 
statistical analysis (i.e. not limited to target-decoy approaches). The file 
reader can then determine the error rate that has been estimated by the 
software in determining those PAGs that pass the reported threshold.
4. The <ProteinDetectionList> MUST contain the CV term “count of identified 
proteins” value= “xsd:integer” (MS:1002404). The value MUST be derived from 
the count of PAGs passing the threshold reported in the file and will be checked by 
validation software. Optional CV terms for alternative methods for counting protein 
identifications or providing ranges can be requested from the working group.
5. Few software packages report “protein clusters” at present (Figure 1C), but for 
those packages that wish to report clusters, a CV term “cluster identifier” value = 
“xsd:integer” SHOULD be used (MS:1002407). The integer identifier MUST be 
shared by all PAGs belonging to the same cluster. If cluster identifiers are used, all 
PAGs MUST have a cluster identifier. An optional term “count of identified 
clusters” value = “xsd:integer” (MS:1002406) MAY be annotated on the 
<ProteinDetectionList>.
6. Every PDH MUST be annotated as either a “leading protein” (MS:1002401) or a 
“non-leading protein” (MS:1002402), as defined in Table 1, within a PAG. This 
recommendation thus makes it explicit for consuming software whether one or 
more proteins have stronger evidence than others in the group (see Table 2 for 
examples).
a. An additional term, “group representative” (MS:1002403) MAY be used to 
annotate one PDH, which is also flagged as a “leading protein”, if the export 
software wishes to enforce that only one of potential several “leading 
proteins” will be interpreted by the consuming software as the representative 
of the group, for example acting as a tiebreaker.
b. If the export software does not explicitly flag one protein as the “group 
representative”, it is assumed that if consuming software requires a single 
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accession to represent the group, an arbitrary choice will be made (among 
“leading proteins” only if these exist).
7. Any PDHs MAY be annotated with terms present in the CV for spectrum/sequence 
same-set, spectrum/sequence subset, spectrum/sequence subsumable, marginally 
distinguished and so on (Table 1).
a. A PDH MAY be annotated with more than one of these terms if appropriate 
to describe the complex set relationships that exist within a group.
b. Developers of software packages MAY propose additional terms for 
describing group membership of PDHs, which will be incorporated into the 
CV.
c. The associated value for these CV terms MAY be used to annotate which 
PDH(s) are the super/same-set of the annotated PDH.
d. There is no expectation that consuming software should be aware of these 
terms, but they may be useful in internal pipeline or visualization software 
packages that are specifically designed to work with this terminology set.
8. Some PDHs could be mapped to more than one PAG, for example where proteins 
are multiply subsumed. To capture these cases, multiple PDHs in different PAGs 
MAY reference the same <DBSequence>.
These guidelines have been developed as a consensus of opinion from the creators of protein 
inference tools, and we believe they can accommodate all currently known approaches – 
including those that are spectrum or peptide-based, statistical and/or set-based, those that 
include only confidently identified PSMs or those that take evidence from weakly identified 
PSMs.
The CV terms and mapping into mzIdentML described have been added to the mzIdentML 
specification document (version 1.2 candidate) – standardization process described in [26]. 
The semantic validation software has been updated to encode these rules and report errors 
(“MUST” rule), warnings (“SHOULD” rule) or informational messages (“MAY” rule) [27]. 
We have also started collecting information describing how concepts from a number of 
different protein inference packages map onto the terminology described here (http://
www.psidev.info/mzidentml#mzid12 – link “Rosetta”). A set of example files is available 
from the project website. The example files can be visualized using the ProteoIDViewer 
software [25], which has been updated to support the new specifications (available from: 
http://code.google.com/p/mzidentml-viewer/). Several examples have been generated by 
different protein inference tools from the same artificially constructed set of spectra, known 
to produce grouping and clustering scenarios when searched against databases containing 
more or less redundancy, thus ensuring we have standardized example files that test the full 
range of biological conditions that might exist and different software approaches.
A number of other issues have been identified since the release of the stable mzIdentML 1.1 
in 2011, which will also be resolved in the release of mzIdentML 1.2. These include explicit 
support for approaches using multiple database search engines; and approaches where 
multiple MS analyses originating from separation of the same sample (e.g. fractionation) are 
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combined in a single database search or the protein inference stage. We have also improved 
support for capturing peptide identifications from de novo sequencing approaches and for 
experiments where statistical analysis was performed at the peptide-level, removing 
redundant PSMs reporting on the same peptide unit. Details are available in the new 
specification document: http://code.google.com/p/psi-pi/source/browse/trunk/
specification_document/specdoc1_2/ and will be described fully in a separate publication.
The PSI will continue to support mzIdentML 1.1 for the foreseeable future (for example the 
mzIdentML 1.1 validator will remain in general use), and it is expected that both 
mzIdentML 1.1 and 1.2 should be supported by importing software and databases. New 
export software will only be expected to create mzIdentML 1.2 however, and over time we 
expect software packages exporting mzIdentML currently to move over to the new 
guidelines.
Concluding remarks
In this work, we have described a standardized terminology for use with the mzIdentML 
data standard for reporting protein identification results in a standard way. The new 
guidelines are released as a new version (1.2) of the standard. We anticipate that the 
mechanism described here for reporting protein grouping results will improve capabilities 
for multi-site collaborations, comparisons between different approaches and consistent 
import of data into public repositories, such as PRIDE [28] and other members of the 
ProteomeXchange Consortium [29]
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Abbreviations
ABRF Association of Biomolecular Resource Facilities
CV Controlled Vocabulary
iPRG Proteome Informatics Research Group
MIAPE Minimum Information About a Proteomics Experiment
PAG Protein Ambiguity Group
PDH Protein Detection Hypothesis
PRIDE PRoteomics IDEntifications (database)
PSI Proteomics Standards Initiative
PSM Peptide Spectrum Match
SNP Single Nucleotide Polymorphism
XSD XML Schema Document
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Figure 1. 
Terminology defined by the iPRG2008 working group, for a protein accession (A), protein 
group (B) and protein cluster (C), with a multiple sequence alignment displaying the 
peptides shared between the different proteins.
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Figure 2. 
A and B. Graphical representation of how the concepts defined in Figure 1 map onto an 
mzIdentML file, following the recommendations presented in this manuscript. Each 
<ProteinDetectionHypothesis> has references back to all peptide spectrum matches (PSMs) 
on which the protein identifications are based (not shown – consult [19] for more details).
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Figure 3. 
A snippet of mzIdentML showing a <ProteinAmbiguityGroup> (lines 5038 to 5095) 
containing four <ProteinDetectionHypothesis> elements (two minimised on lines 5068 and 
5080). In this example, the first PDH (lines 5039-5055) has been flagged as both a “leading 
protein” and “group representative” (lines 5051 and 5052). The second PDH (lines 
5056-5067) has been assigned as a “non-leading protein” (line 5066) and a “sequence sub-
set protein” (line 5065). CV terms assigned to the PAG-level are on lines 5092-5094, 
including the mandatory term “protein group passes threshold” (line 5092).
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Table 1
New CV terms for reporting protein set (group) relationships and global statistics about the protein 
identification results. The semantic validation software for mzIdentML (v.1.2) reports an error (MUST), a 
warning (SHOULD) or an informational message (MAY) if these terms are not reported within the file.
mzIdentML context CV term Values Requirement level Description
ProteinDetectionList count of identified proteins xsd:integer MUST The value reported MUST 
equal the number of PAGs 
with “protein group passes 
threshold” value = “true”
ProteinDetectionList count of identified clusters xsd:integer MAY If protein clusters have been 
reported in the file, the 
exporter may choose to 
annotate the 
ProteinDetectionList with the 
number identified above 
threshold.
ProteinAmbiguity-Group number of distinct protein 
sequences
xsd:integer MAY The number of distinct 
protein sequences among the 
PDHs in the group. For 
example, if there are two 
PDHs with different 
identifiers that have identical 
full length sequences, the 
value would be 1.
ProteinAmbiguity-Group cluster identifier xsd:integer MAY An identifier applied to 
protein groups to indicate 
that they are linked by shared 
peptides.
ProteinDetection-Hypothesis leading protein
OR
non-leading protein
- MUST
OR
MUST
Every PDH in each PAG 
MUST be flagged as a 
leading protein or a non-
leading protein and each 
PAG MUST contain at least 
one leading protein, but 
MAY contain more than one. 
A “leading protein” is 
defined as a protein that has 
the strongest or near 
strongest (further explained 
in Table 2) set of evidence 
for being present in the 
sample studied, amongst the 
grouped protein accessions. 
A “non-leading protein” is 
defined as a protein that has 
(substantially) less evidence 
than other proteins within the 
same group, and is thus less 
likely to have been present in 
the sample studied.
ProteinDetection-Hypothesis group representative - MAY Each PAG MAY contain 
zero or one PDH flagged as 
the group representative, if 
the software wishes to flag a 
preference (often arbitrary or 
for example based on 
alphabetical ordering) 
amongst the leading proteins. 
The group representative 
term can thus be viewed a 
“tiebreaker” if the export 
software wishes to make this 
distinction.
ProteinDetection-Hypothesis Sequence Same-Set Protein xsd: 
“list_of_strings” 
MAY A protein that is 
indistinguishable or 
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mzIdentML context CV term Values Requirement level Description
space separated 
list of PDH IDs 
that are same-set.
equivalent to another protein 
in the group, having matches 
to an identical set of peptide 
sequences.
ProteinDetection-Hypothesis Spectrum Same-Set Protein xsd: 
“list_of_strings” 
space separated 
list of PDH IDs 
that are same-set.
MAY A protein that is 
indistinguishable or 
equivalent to another protein 
in the group, having PSMs 
derived from the same set of 
spectra.
ProteinDetection-Hypothesis Sequence Subset Protein xsd: 
“list_of_strings” 
space separated 
list of PDH IDs 
that are super-set.
MAY A protein for which the 
matched peptide sequences 
are a subset of the matched 
peptide sequences for 
another protein in the group.
ProteinDetection-Hypothesis Spectrum Subset Protein xsd: 
“list_of_strings” 
space separated 
list of PDH IDs 
that are super-set.
MAY A protein for which the 
matched spectra are a subset 
of the matched spectra for 
another protein in the group.
ProteinDetection-Hypothesis Sequence Multiply Subsumable 
Protein
xsd: 
“list_of_strings” 
space separated 
list of PDH IDs 
that subsume this 
PDH.
MAY A protein for which the 
matched peptide sequences 
are the same, or a subset of, 
the matched peptide 
sequences for two or more 
other proteins combined. 
These other proteins need not 
all be in the same group.
ProteinDetection-Hypothesis Spectrum Multiply Subsumable 
Protein
xsd: 
“list_of_strings” 
space separated 
list of PDH IDs 
that subsume this 
PDH.
MAY A protein for which the 
matched spectra are the 
same, or a subset of, the 
matched spectra for two or 
more other proteins 
combined. These other 
proteins need not all be in the 
same group.
ProteinDetection-Hypothesis Marginally distinguished protein - MAY Assigned to a non-leading 
PDH that has some 
independent evidence to 
support its presence relative 
to the leading protein(s) e.g. 
the PDH may have a unique 
peptide but not sufficient to 
be promoted as, for example, 
a leading protein of another a 
PAG.
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Table 2
A summary of grouping options and recommendation for CV term annotations, assuming a group of four 
related proteins A-D.
Scenario Software preference Encoding
Software scores A and B as 
same-set, C and D as subset.
Software wishes to make A the group 
representative (arbitrary)
A = leading protein & group representative
B = leading protein
C = non-leading protein
D = non-leading protein (Use of formal same-set and 
subset notation is also allowed but optional)
As above Software does not wish to choose which is 
the group representative
A = leading protein
B = leading protein
C = non-leading protein
D = non-leading protein
Software scores A as best 
protein, B, C and D are all 
subset or subsumed
N/A A = leading protein
B = non-leading protein
C = non-leading protein
D = non-leading protein
Software scores all four 
proteins as same-set or more 
generally as having equal 
evidence
Software wishes to make A the group 
representative (arbitrary)
A = leading protein & group representative
B = leading protein
C = leading protein
D = leading protein
As above Software does not wish to choose which is 
the group representative
A = leading protein
B = leading protein
C = leading protein
D = leading protein
Software scores A as having 
slightly more evidence than 
B. B has additional weak 
independent evidence 
relative to A. C and D have 
less evidence than either A 
or B.
Software wishes to assign A as the leading 
protein and the independent evidence for B 
is not sufficient for it to form a new PAG.
A = leading protein
B = non-leading protein & marginally distinguished 
(optional)
C = non-leading protein
D = non-leading protein
As above Software does not wish to choose which is 
the leading protein out of A and B or group 
representative
A = leading protein
B = leading protein
C = non-leading protein
D = non-leading protein
As above Software does not wish to choose which is 
the leading protein but does select a group 
representative
A = leading protein & group representative
B = leading protein
C = non-leading protein
D = non-leading protein
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